Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
University Health Network, Toronto
Eastern Cooperative Oncology Group
Jonsson Comprehensive Cancer Center
Umeå University
Royal North Shore Hospital
Royal North Shore Hospital
NRG Oncology
NRG Oncology
RTOG Foundation, Inc.
Mayo Clinic